Trial Profile
Phase 1, Single-center, Open-label, Randomized, Crossover Design Clinical Trial in Healthy Normal Volunteers to Evaluate Insulin Exposure and Dose-proportionality Following Inhalation of Technosphere Insulin Inhalation Powder (3 U and 4 U Insulin/mg) Using the Gen2 Inhaler
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2012
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 06 Jun 2011 New trial record